We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PITX2 Prostate Cancer Molecular Classification Test Transferred to Affymetrix Diagnostic Platform

News   Dec 18, 2006

 
PITX2 Prostate Cancer Molecular Classification Test Transferred to Affymetrix Diagnostic Platform
 
 
 

RELATED ARTICLES

Human Cell Atlas Study Sheds Light on Maternal-Fetal Interface

News

The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta.

READ MORE

3D Microfluidic Platform Enables Neuronal Chemotactic Assays

News

Shedding light on neural regeneration mechanism by recognizing subtle variation in the gradient profiles of guidance molecules.

READ MORE

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE